⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 4, 2004AJP Renal Physiology

Vascular localization of soluble epoxide hydrolase in the human kidney

View Full Paper

Ask AI

Bookmark

Share

Authors

ZYZhigang YuUniversity of Michigan BDBenjamin B. DavisUniversity of Toronto CMChristophe MorisseauSylvester Comprehensive Cancer Center

Discussion

Loading...

Member takes

Implication

Extends prior animal data on EETs to humans; leaves open whether sEH inhibition alters renal outcomes.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yu et al. (2004) studied this question.

synapsesocial.com/papers/6a7c2873edcd5d2e111f6c41 https://doi.org/10.1152/ajprenal.00165.2003

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Role of cytochrome P-450 epoxygenase metabolites in EGF signaling in renal proximal tubule1995 · 47 citations
2Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation2000 · 341 citations
3Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation2002 · 120 citations
4Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide2002 · 45 citations
5Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta1991 · 80 citations